Table 2 Ocular VEMP N₁₀, P₁₅ latencies (in ms), N₁₀-P₁₅ amplitude (in μV), and IAD in the three studied groups

Ocular VEMP

P₁₅latency

(n= 20)

(n= 20)

(n= 19)

Min.–max.

13.67–17.84

13.34–17.67

14.34–22.17

0.062

0.969

Mean ± SD.

16.13 ± 1.12

16.01 ± 1.13

16.43 ± 1.90

Median

16.34

16.34

15.84

N₁₀latency

(n= 20)

(n= 20)

(n= 19)

Min.–max.

10.0–12.84

9.17–14.0

10.17–18.51

2.723

0.256

Mean ± SD.

11.17 ± 1.01

11.61 ± 1.05

11.98 ± 2.17

Median

10.75

11.67

11.67

N₁₀-P₁₅amplitude

(n= 20)

(n= 20)

(n= 19)

Min.–max.

2.56–7.87

2.11–9.06

1.59–13.34

0.295

0.863

Mean ± SD.

4.20 ± 1.72

4.40 ± 1.64

4.87 ± 2.91

Median

3.54

3.90

4.11

IAD

Control (n* = 10)

Migraine (n* = 10)

MAV (n* = 9)

H

P

Min.–max.

0.17–2.33

0.16–2.33

0.16–1.67

1.658

0.437

Mean ± SD.

1.30 ± 0.74

0.85 ± 0.70

0.83 ± 0.64

Median

1.34

0.58

1.0

Min.–Max.

14.66–17.51

13.34–17.67

15.0–20.34

0.305

0.859

Mean ± SD.

16.14 ± 0.97

15.96 ± 1.37

16.38 ± 1.61

Median

16.17

16.34

15.84

Min.–Max.

0.25–42.35

0.54–36.65

1.27–53.85

4.338

0.114

Mean ± SD.

10.88 ± 14.7

16.36 ± 12.47

24.76 ± 18.25

Median

5.10

12.87

27.68